Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05554172 · ClinicalTrials.gov registry record · NA

Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders

A NA study of Anorexia Nervosa, sponsored by Icahn School of Medicine at Mount Sinai.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT05554172 is a NA study of Anorexia Nervosa that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 30 participants, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05554172, a NA study of Anorexia Nervosa, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

This project includes a 4-week randomized trial comparing pre-meal vagal nerve stimulation (taVNS) to pre-meal sham stimulation. The aims will assess if taVNS results in greater satisfaction, greater calorie consumption, less self-reported fullness, decrease in eating disorder symptoms, and less anxiety than sham stimulation.

Conditions Studied

Interventions

  • DEVICE Sham
  • DEVICE taVNS

Study Locations (1)

New York

  • Department of Psychiatry, Eating and Weight Disorders Program - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2022-12-13
Est. Completion 2026-10
Phase NA

What the Registry Record Tells You About NCT05554172

The ClinicalTrials.gov registry entry for NCT05554172 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 949-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (97% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anorexia Nervosa appearing as the primary indexed condition, and to 2 interventions - of which Sham is the first listed.

NCT05554172 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05554172 about?

NCT05554172 is a clinical study titled "Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders". This project includes a 4-week randomized trial comparing pre-meal vagal nerve stimulation (taVNS) to pre-meal sham stimulation. The aims will assess if taVNS results in greater satisfaction, greater calorie consumption, less self-reported fullness, decrease in eating disorder symptoms, and less anx...

What is the current status of trial NCT05554172?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2022-12-13. Estimated completion is 2026-10.

What conditions does trial NCT05554172 study?

This clinical trial studies the following conditions: Anorexia Nervosa.

What interventions are being tested in trial NCT05554172?

The interventions under investigation include: Sham (DEVICE), taVNS (DEVICE).

Who is sponsoring clinical trial NCT05554172?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05554172 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anorexia Nervosa

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.